Vera Therapeutics, Inc. Class short interest in 2023
In 2023, Vera Therapeutics, Inc. Class's disclosed short interest ran from 4.48% of shares outstanding on 13 Jan 2023 to 14.14% on 29 Dec 2023, a change of +9.66 percentage points. The year's high was 14.14% on 29 Dec 2023 and its low 4.48% on 13 Jan 2023, averaging 9.29% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.61 days on 30 Nov 2023. Full history: Vera Therapeutics, Inc. Class.
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 4.48% (13 Jan 2023)
- End of year
- 14.14% (29 Dec 2023)
- Change
- +9.66 pp
- High
- 14.14% (29 Dec 2023)
- Low
- 4.48% (13 Jan 2023)
- Average
- 9.29%
- Highest days to cover
- 15.61 (30 Nov 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 4.48% | 1.00 | |
| 31 Jan 2023 | 5.52% | 2.01 | |
| 15 Feb 2023 | 8.14% | 2.30 | results (8-K) |
| 28 Feb 2023 | 8.43% | 5.07 | |
| 15 Mar 2023 | 9.73% | 5.24 | |
| 31 Mar 2023 | 12.92% | 7.11 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 9.20% | 5.70 | |
| 28 Apr 2023 | 11.96% | 10.18 | |
| 15 May 2023 | 6.81% | 11.06 | 10-Q filed, results (8-K) |
| 31 May 2023 | 6.45% | 8.96 | |
| 15 Jun 2023 | 8.05% | 3.02 | |
| 30 Jun 2023 | 7.79% | 2.25 | |
| 14 Jul 2023 | 7.60% | 8.15 | |
| 31 Jul 2023 | 6.97% | 7.33 | |
| 15 Aug 2023 | 7.37% | 8.62 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 8.56% | 11.52 | |
| 15 Sep 2023 | 8.30% | 4.70 | |
| 29 Sep 2023 | 11.04% | 9.28 | |
| 13 Oct 2023 | 12.34% | 10.65 | |
| 31 Oct 2023 | 11.19% | 7.55 | |
| 15 Nov 2023 | 11.31% | 7.26 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 12.05% | 15.61 | |
| 15 Dec 2023 | 12.71% | 12.77 | |
| 29 Dec 2023 | 14.14% | 15.38 |
See also: Vera Therapeutics, Inc. Class's full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.